Skip to product information
1 of 5

HeadaTerm

HeadaTerm 2 Migraine Headache Relief Device

HeadaTerm 2 Migraine Headache Relief Device

Regular price $104.99
Regular price $129.99 Sale price $104.99
Sale Sold out
Shipping calculated at checkout.
Quantity

HeadaTerm 2 is a clinically proven, safe, and effective medical device worn on users’ foreheads that uses none-invasive neuronal electrical stimulation technology to prevent and treat primary headache, including migraine, tension headache, cluster headache.

✅ FDA OTC approved for migraine relief.
✅ Rechargeable for repeated use.
✅ Manual adjustment for personalized stimulation.

View full details
sale up to 25% off

Exclusive Early Bird Price for the HeadaTerm2

Act fast! Only 30 early bird slots available – reserve yours now!

Discount Code: PREHT25

FDA3.png__PID:276adba0-971c-4744-a1b0-3d853b7c7d8d

Safety Certification

FDA-approved for safety and effectiveness.

M.png__PID:054cedf3-c9d7-4a32-8d05-ec537cbca934

Physical Therapy

Fast-acting relief with eTNS technology and no side effects.

Non-Prescription.png__PID:dba0971c-8744-41b0-bd85-3b7c7d8d5831

Non-prescription

Affordable home medical products.

F.png__PID:c77e054c-edf3-49d7-ba32-8d05ec537cbc

HSA/FSA Eligible

Vouchers available for reimbursement upon purchase.

Up to 27% more effective than oral medicine

Published by Emergency Medicine in the United States

Learn More
VS.jpg__PID:220f4ffb-86f1-4388-8368-a0f264c91b19

HOW IT WORKS

Y01.jpg__PID:3a8272e3-4739-41c7-b2f6-292d19e5f5d8Y02.jpg__PID:8272e347-39b1-47f2-b629-2d19e5f5d827

Primary headaches, such as migraine, are transmitted by the supraorbital nerve and the supratrochlear nerve. HeadaTerm introduces precise electric impulses from the user’s forehead to act on these nerves and reduce the migraine signals transmitted. The device avoids any drug effects, making it appropriate a wide range of users.

Three Major Benefits of HeadaTerm 2

左(1).jpg__PID:8c85f32e-e998-4687-a288-578a95c57370
1.png__PID:f32ee998-e687-4288-978a-95c57370f2fe

Treating Migraine Headaches

58%

Effective in Significantly Relieving Acute Migraine Symptoms

2.png__PID:2ee998e6-8762-4857-8a95-c57370f2feeb

Relieve Migraine

86%

Effective in Reducing Migraine Pain Levels

3.png__PID:e998e687-6288-478a-95c5-7370f2feebe0

Prevent Migraine

64%

Effective in Reducing the Incidence of Migraines

Kidzone

For every HeadaTerm 2 Anti-migraine Device purchased, $1 will be donated to The American Legion.

*Donate every 5 months and publish the donation voucher

Learn more

Guarantee

100% secure checkout

30 Days Money Back Guarantee

1-year warranty guarantee

Worldwide Shipping

Fast delivery available

Free Shipping on All Orders Over $30

Multi-country transfer within 5-7 days

BrandHeadaTerm
Rechargeable
PrincipleeTNS technology
DesignerCanada
IndicationsThe TENS device-HeadaTerm 2 is indicated for the prophylactic treatment of episodic migraine in patients 18 years of age or older.
CertificateFDA, CE, TGA, HC, ISO

Relieve Migraine Without Medication

Portable

100% Drug-Free

Easy Operation

Quick Effect

New Generation Of Targeted Thrapeutic Anti-Migraine Device

Primary headaches are debilitating conditions that are extremely common among people. Drug treatments are the popular solutions for many patients, but just like with anti-nausea drugs, there are side effects that often turn people away. HeadaTerm offers a drug-free treatment without any side effects.

More advanced than HeadaTerm Generation 1.

2c2d7db8437132ccb6316392ac5a58d.png__PID:570c3901-c22e-426f-a0ee-2dcd11cf4b33

How to use

Learn more
搜狗截图20240415154023.png__PID:a2322d67-b7cd-4b73-bca4-5bf026700d4d

HeadaTerm 2 Electrode (3-pack)

20240319091110.png__PID:f0433b25-769b-4652-9bfa-82a5b6d1cfdf

HeadaTerm Official Sustainability Plan

Every 5 used devices can be exchanged for 1 new device.

Learn More

EmeTerm® HeadaTerm Testimonials

Customers Testimonials

Reference

  • Hokenek N M, Erdogan M O, Hokenek U D, et al. Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: A randomize controlled trial[J]. The American Journal of Emergency Medicine, 2021, 39: 80-85.
  • Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain. 2003 Apr;4(3):109-21.
  • Shealy CN. Transcutaneous electrical nerve stimulation: the treatment of choice for pain and depression. J Altern Complement Med. 2003 Oct;9(5):619-23.
  • Huang W, Kutner N, Bliwise DL. Autonomic activation in insomnia: the case for acupuncture. J Clin Sleep Med. 2011 Feb 15;7(1):95-102.
  • Kirsch DL, Nichols F. Cranial electrotherapy stimulation for treatment of anxiety, depression, and insomnia. Psychiatr Clin North Am. 2013 Mar;36(1):169-76.
  • Schoenen J, Vandersmissen B, Jeangette S, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013 Feb 19;80(8):697-704.
  • Nihat M. Hokenek, MD. Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: A randomized controlled trial. VOLUME 39, P80-85, JANUARY 01, 2021